Curaleaf Holdings, Inc. (TSX:CURA)
Canada · Delayed Price · Currency is CAD 11.51
-3.70 (-24.33%)
Inactive · Last trade price on Jun 5, 2026
Curaleaf Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,286 | 1,268 | 1,334 | 1,347 | 1,275 | 1,196 | |
Revenue Growth | -1.25% | -4.96% | -0.92% | 5.58% | 6.64% | 90.86% |
Cost of Revenue | 653 | 637.11 | 693.52 | 732.18 | 649 | 626.16 |
Gross Profit | 632.75 | 631.02 | 640.78 | 614.45 | 626.42 | 569.83 |
Selling, General & Admin | 435.45 | 428.44 | 418.53 | 414.77 | 419.88 | 386.64 |
Operating Expenses | 615.91 | 605.57 | 616.03 | 571.57 | 561.43 | 511.26 |
Operating Income | 16.84 | 25.45 | 24.74 | 42.88 | 64.99 | 58.57 |
Interest Expense | -101.11 | -100.83 | -100.62 | -100.38 | -88.84 | -78.51 |
Interest & Investment Income | 0.7 | 0.66 | 0.78 | 0.02 | 0.14 | 0.63 |
Currency Exchange Gain (Loss) | 0.66 | 3.69 | -1.62 | - | - | - |
Other Non Operating Income (Expenses) | 4 | 3.6 | 6.1 | 4.59 | -11.76 | -0.17 |
EBT Excluding Unusual Items | -78.91 | -67.43 | -70.62 | -52.89 | -35.48 | -19.48 |
Merger & Restructuring Charges | -9.7 | -9.7 | -56.8 | -9.1 | -34.1 | - |
Impairment of Goodwill | - | - | - | -50.7 | -55.42 | -3.18 |
Gain (Loss) on Sale of Investments | -1.38 | -1.44 | 4.82 | 2.07 | 21.95 | -2.09 |
Gain (Loss) on Sale of Assets | -1.78 | -3.05 | 4.62 | -8.54 | -0.55 | -4.71 |
Asset Writedown | 5.42 | 1.72 | 4.36 | -7.27 | 6.91 | -11.39 |
Other Unusual Items | -4.09 | 1.69 | 0.26 | 2.07 | 10.21 | -21.34 |
Pretax Income | -90.44 | -78.21 | -113.36 | -124.37 | -86.49 | -62.2 |
Income Tax Expense | -8.67 | 123.69 | 98.25 | 114.59 | 178.82 | 152.45 |
Earnings From Continuing Operations | -81.77 | -201.9 | -211.61 | -238.96 | -265.31 | -214.64 |
Earnings From Discontinued Operations | -16.35 | -26.25 | -10.4 | -51.38 | -111.62 | - |
Net Income to Company | -98.12 | -228.15 | -222.01 | -290.34 | -376.93 | -214.64 |
Minority Interest in Earnings | -2.08 | -2.92 | 6.58 | 9.14 | 6.83 | 8.7 |
Net Income | -100.21 | -231.07 | -215.42 | -281.2 | -370.1 | -205.94 |
Preferred Dividends & Other Adjustments | 29.35 | 42.29 | 22.75 | - | - | - |
Net Income to Common | -129.56 | -273.36 | -238.17 | -281.2 | -370.1 | -205.94 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 257 | 254 | 247 | 241 | 237 | 233 |
Shares Outstanding (Diluted) | 257 | 254 | 247 | 241 | 237 | 233 |
Shares Change | 3.60% | 2.87% | 2.31% | 1.82% | 1.77% | 25.41% |
EPS (Basic) | -0.50 | -1.08 | -0.96 | -1.16 | -1.56 | -0.88 |
EPS (Diluted) | -0.50 | -1.08 | -0.96 | -1.16 | -1.56 | -0.88 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 55.92 | 74.27 | 71.19 | 9.82 | -88.24 | -230.24 |
Free Cash Flow Per Share | 0.22 | 0.29 | 0.29 | 0.04 | -0.37 | -0.99 |
Gross Margin | 49.21% | 49.76% | 48.02% | 45.63% | 49.11% | 47.64% |
Operating Margin | 1.31% | 2.01% | 1.85% | 3.18% | 5.10% | 4.90% |
Profit Margin | -10.08% | -21.56% | -17.85% | -20.88% | -29.02% | -17.22% |
Free Cash Flow Margin | 4.35% | 5.86% | 5.33% | 0.73% | -6.92% | -19.25% |
EBITDA | 212.47 | 222.06 | 256.2 | 238.76 | 220.97 | 179.12 |
EBITDA Margin | 16.53% | 17.51% | 19.20% | 17.73% | 17.32% | 14.98% |
D&A For EBITDA | 195.63 | 196.61 | 231.46 | 195.88 | 155.98 | 120.54 |
EBIT | 16.84 | 25.45 | 24.74 | 42.88 | 64.99 | 58.57 |
EBIT Margin | 1.31% | 2.01% | 1.85% | 3.18% | 5.10% | 4.90% |
Revenue as Reported | 1,286 | 1,268 | 1,334 | 1,347 | 1,275 | 1,196 |
Advertising Expenses | - | 20.7 | 18.4 | 12 | 11.3 | 17.8 |